193 related articles for article (PubMed ID: 31582517)
1. Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment.
Savic LJ; Schobert IT; Peters D; Walsh JJ; Laage-Gaupp FM; Hamm CA; Tritz N; Doemel LA; Lin M; Sinusas A; Schlachter T; Duncan JS; Hyder F; Coman D; Chapiro J
Clin Cancer Res; 2020 Jan; 26(2):428-438. PubMed ID: 31582517
[TBL] [Abstract][Full Text] [Related]
2. Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
Doemel LA; Santana JG; Savic LJ; Gaupp FML; Borde T; Petukhova-Greenstein A; Kucukkaya AS; Schobert IT; Hamm CA; Gebauer B; Walsh JJ; Rexha I; Hyder F; Lin M; Madoff DC; Schlachter T; Chapiro J; Coman D
Eur Radiol; 2022 Apr; 32(4):2437-2447. PubMed ID: 34718844
[TBL] [Abstract][Full Text] [Related]
3. Idarubicin-Loaded ONCOZENE Drug-Eluting Bead Chemoembolization in a Rabbit Liver Tumor Model: Investigating Safety, Therapeutic Efficacy, and Effects on Tumor Microenvironment.
Borde T; Laage Gaupp F; Geschwind JF; Savic LJ; Miszczuk M; Rexha I; Adam L; Walsh JJ; Huber S; Duncan JS; Peters DC; Sinusas A; Schlachter T; Gebauer B; Hyder F; Coman D; van Breugel JMM; Chapiro J
J Vasc Interv Radiol; 2020 Oct; 31(10):1706-1716.e1. PubMed ID: 32684417
[TBL] [Abstract][Full Text] [Related]
4. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
Savic LJ; Doemel LA; Schobert IT; Montgomery RR; Joshi N; Walsh JJ; Santana J; Pekurovsky V; Zhang X; Lin M; Adam L; Boustani A; Duncan J; Leng L; Bucala RJ; Goldberg SN; Hyder F; Coman D; Chapiro J
Radiology; 2020 Sep; 296(3):575-583. PubMed ID: 32633675
[TBL] [Abstract][Full Text] [Related]
5. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.
Lee IJ; Lee M; Kim SJ; Kim YK; Won JY; Chung JW
J Vasc Interv Radiol; 2018 Aug; 29(8):1078-1084. PubMed ID: 29910164
[TBL] [Abstract][Full Text] [Related]
6. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
7. Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.
van Breugel JMM; Geschwind JF; Mirpour S; Savic LJ; Zhang X; Duran R; Lin M; Miszczuk M; Liapi E; Chapiro J
Theranostics; 2019; 9(13):3674-3686. PubMed ID: 31281506
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
Savic LJ; Chapiro J; Funai E; Bousabarah K; Schobert IT; Isufi E; Geschwind JH; Stark S; He P; Rudek MA; Perez Lozada JC; Ayyagari R; Pollak J; Schlachter T
Eur Radiol; 2021 May; 31(5):3002-3014. PubMed ID: 33063185
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Infusion of iRGD-Modified ZrO
Xie Y; Qi X; Xu K; Meng X; Chen X; Wang F; Zhong H
J Vasc Interv Radiol; 2019 Dec; 30(12):2026-2035.e2. PubMed ID: 31590966
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.
Duran R; Mirpour S; Pekurovsky V; Ganapathy-Kanniappan S; Brayton CF; Cornish TC; Gorodetski B; Reyes J; Chapiro J; Schernthaner RE; Frangakis C; Lin M; Sun JD; Hart CP; Geschwind JF
Clin Cancer Res; 2017 Jan; 23(2):536-548. PubMed ID: 27440271
[TBL] [Abstract][Full Text] [Related]
11. Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner.
Coman D; Peters DC; Walsh JJ; Savic LJ; Huber S; Sinusas AJ; Lin M; Chapiro J; Constable RT; Rothman DL; Duncan JS; Hyder F
Magn Reson Med; 2020 May; 83(5):1553-1564. PubMed ID: 31691371
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor model.
Gao F; Qian T; Chen MZ; Yin HB; Xu YL
Diagn Interv Radiol; 2015; 21(3):241-6. PubMed ID: 25858527
[TBL] [Abstract][Full Text] [Related]
13. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
[TBL] [Abstract][Full Text] [Related]
14. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
15. A high-throughput imaging platform to characterize extracellular pH in organotypic three-dimensional in vitro models of liver cancer.
Savic LJ; Schobert IT; Hamm CA; Adam LC; Hyder F; Coman D
NMR Biomed; 2021 Mar; 34(3):e4465. PubMed ID: 33354836
[TBL] [Abstract][Full Text] [Related]
16. [Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits].
Liu X; Luo XP; Cao WT; Deng H
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):611-6. PubMed ID: 23207156
[TBL] [Abstract][Full Text] [Related]
17. [Transhepatic arterial embolization with superparamagnetic iron oxide and lipiodol for the treatment of VX2 tumor in rabbits].
Liang Q; Deng L; Feng Z; Liu X; Ding J; Hu P; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1248-1256. PubMed ID: 29187650
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis.
Geschwind JF; Artemov D; Abraham S; Omdal D; Huncharek MS; McGee C; Arepally A; Lambert D; Venbrux AC; Lund GB
J Vasc Interv Radiol; 2000; 11(10):1245-55. PubMed ID: 11099235
[TBL] [Abstract][Full Text] [Related]
19. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
[TBL] [Abstract][Full Text] [Related]
20. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
